A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body.

Scientists have found a surprising new way to make certain cancer drugs work dramatically better – by helping them get inside ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

Trastuzumab deruxtecan approved to treat adults with HER2-positive cancer that’s spread or can’t be removed by surgery.

Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...

Cancer drugs conferring low or no therapeutic benefits accounted for $6.7 billion in post-rebate Medicare spending in 2022.

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

Part C should provide similar coverage, and Part D will pay for some prescription drugs. Medicare Part B pays 80% of your care provider’s bills for prescribed, approved cancer treatments.

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...